Lv1
50 积分 2024-06-17 加入
Dual targeting of TNF and IL-23 by a bispecific antibody in ulcerative colitis
3个月前
已关闭
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
3个月前
已完结
Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven®)
8个月前
已完结
皖公网安备34019202002308